Ionis Pharmaceuticals Inc (NAS:IONS)
$ 38.8 -0.28 (-0.72%) Market Cap: 5.66 Bil Enterprise Value: 4.94 Bil PE Ratio: 0 PB Ratio: 19.11 GF Score: 74/100

Ionis Pharmaceuticals Inc Neurological Disease Franchise Webcast Transcript

May 07, 2019 / 05:30PM GMT
Release Date Price: $67.62 (-7.04%)
Operator

Good afternoon and welcome to the Ionis Pharmaceuticals neurological disease pipeline webcast. As a reminder, this webcast is being recorded.

At this time, I would now like to turn conference over to Wade Walke, Vice President of Investor Relations. Wade, please begin.

D. Wade Walke;Stanley T.
Ionis Pharmaceuticals, Inc. - VP of IR

Thank you, Karl. Before we begin, I encourage everyone who's not yet launched the webcast to proceed to the investor section of the Ionis website and find a link to this webcast and the related slides.

I would like to draw your attention to Slide 2, which contains our forward-looking language statement. We'll be making forward-looking statements, which are based on our current expectations and beliefs. These statements are subject to certain risks and uncertainties and our actual results may differ materially, and created to consult the risk factors discussed in our SEC filings for additional detail.

And with that, I'll turn the call over to Dr. Stan Crooke, CEO and Chairman at Ionis.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot